The future looks promising for ambulatory surgery centers (ASCs) as the health care industry’s focus on cost efficiencies shifts toward where surgical procedures are performed. Surgeries with increasing complexity, once limited to hospitals, are now shifting to ASCs, indicating continued growth for the foreseeable future. A recent Jefferies equity research report highlighted the structural tailwinds driving this transformation and projected 6% to 8% growth for the ASC sector through … [Read more...]
Tenet Healthcare Expands ASC Network with Continued Investment Strategy
Reimbursement rate uncertainty and a regulatory landscape in flux won’t stand in the way of ambulatory surgery center (ASC) growth for Tenet Healthcare Corporation (NYSE: THC). Tenet leaders continue to double down on the ASC market, with plans to prioritize capital investments to grow its subsidiary, United Surgical Partners International (USPI), through M&A over the next several months. Executives discussed those plans and more during the company’s 2025 third-quarter earnings call on … [Read more...]
Tenet Sues BCBS of Florida, Health Options for $21M in Disputed Medical Claims – Including ASC Services
Tenet Healthcare Corp. (NYSE: THC) providers – including its ambulatory surgery center (ASC) arm – are suing Blue Cross and Blue Shield of Florida and affiliate Health Options Inc. The suit alleges the insurers underpaid or denied more than $21 million in claims for care provided to insured patients across Florida. That care included both inpatient and outpatient health care services, according to Tenet. Filed July 3 in the 11th Judicial Circuit Court of Florida, the more than 400-page … [Read more...]
Tenet CEO: ‘Significant Opportunity’ Ahead for ASC, Outpatient Growth
Tenet Healthcare (NYSE: THC) is leaning further into ambulatory and outpatient growth strategies after a strong start to 2025, CEO Saum Sutaria said Tuesday during the company’s Q1 earnings call. "We see significant opportunity for growth," Sutaria said. The Dallas-based company's ambulatory platform, United Surgical Partners International (USPI), saw a 20% increase in net operating revenues compared to the previous year, at $1.19 billion, compared to $995 million the past … [Read more...]
Tenet Mitigating Policy Risks with Payer Mix, High-Acuity Volume
Tenet Healthcare Corporation (NYSE: THC) is pivoting toward higher-acuity services to mitigate policy risks in the face of legislative uncertainties, including Medicaid cuts and site neutrality. The company has already increased its higher-acuity procedures volume, but that trend will continue. “Our focus is on continuing to build and expand our high-margin service lines,” CEO Saum Sutaria said at the recent Barclays Global Healthcare Conference. To that tune, Tenet is investing in … [Read more...]
Trump’s Return: How the New Administration Could Shape Future of Ambulatory Surgery Centers
The 2024 presidential election has ushered in Donald Trump’s return to the White House. With it, questions arise about the future of health care policy and implications for the ambulatory surgery center (ASC) industry. “President Trump was president for four years, so it’s not like we’re walking into this completely blind,” J. Blake Peart, managing director at health care advisory firm Vertess, told ASC News. The Affordable Care Act (ACA) remains a critical issue, Peart said. During his … [Read more...]
Tenet CEO Anticipates More Favorable Regulatory Landscape for ASC Consolidation
With the potential for regulatory changes on the horizon, particularly regarding antitrust policies, Tenet Healthcare Corporation (NYSE: THC) CEO Saum Sutaria said that a more favorable environment for mergers and acquisitions in the coming years could support further healthcare consolidation. Such a change would support ambulatory surgery center (ASC) dealmaking, although Sutaria noted that ASC merger and acquisition activity is unlikely to trigger antitrust concerns under any circumstances … [Read more...]
Tenet Healthcare CEO: ASC Business Experiencing ‘Incredibly Busy Year’
Tenet Healthcare Corporation (NYSE: THC) is experiencing an “incredibly busy year” when it comes to United Surgical Partners International (USPI), its large ambulatory surgery center (ASC) business. In part, all of the action is driven by an increase in ASC higher-acuity caseload, with total joint replacements in Tenet’s ASCs up 23% year over year, with ongoing growth in urology and gastrointestinal (GI) procedures as well. Overall same-facility surgery volumes for Tenet’s ambulatory arm were … [Read more...]